Methyl(2S)-2-(tert-butoxy)-2-[(22S)-5-ethenyl-17-fluoro-4,22,28-trimethyl-21,27-dioxa-1,7,34-triazahexacyclo[26.2.2.16,9.110,14.02,7.015,20]tetratriaconta-2,4,6(34),8,10(33),11,13,15(20),16,18-decaen-3-yl]acetate → Methyl(2S)-2-(tert-butoxy)-2-[(22S)-17-fluoro-5-formyl-4,22,28-trimethyl-21,27-dioxa-1,7,34-triazahexacyclo[26.2.2.16,9.110,14.02,7.015,20]tetratriaconta-2,4,6(34),8,10(33),11,13,15(20),16,18-decaen-3-yl]acetate

HRID 1482120Notes

Reaction equation

HRID 1482120 reaction equation
C(O[C@@H](C1C(C)=C(C=C)C2=NC3=CN2C=1N1CCC(C)(OCCCC[C@H](C)OC2C=CC(F)=CC=2C2C=C3C=CC=2)CC1)C(OC)=O)(C)(C)C.[C:51]([O:55][C@@H:56]([C:61]1[C:90]([CH3:91])=[C:89]([CH:92]=[O:93])[C:88]2=[N:94][C:85]3=[CH:86][N:87]2[C:62]=1[N:63]1[CH2:100][CH2:99][C:66]([CH3:101])([O:67][CH2:68][CH2:69][CH2:70][CH2:71][C@H:72]([CH3:98])[O:73][C:74]2[CH:75]=[CH:76][C:77]([F:97])=[C:78](F)[C:79]=2[C:80]2[CH:95]=[C:84]3[CH:83]=[CH:82][CH:81]=2)[CH2:65][CH2:64]1)[C:57]([O:59][CH3:60])=[O:58])([CH3:54])([CH3:53])[CH3:52]>>[C:51]([O:55][C@@H:56]([C:61]1[C:90]([CH3:91])=[C:89]([CH:92]=[O:93])[C:88]2=[N:94][C:85]3=[CH:86][N:87]2[C:62]=1[N:63]1[CH2:64][CH2:65][C:66]([CH3:101])([O:67][CH2:68][CH2:69][CH2:70][CH2:71][C@H:72]([CH3:98])[O:73][C:74]2[CH:75]=[CH:76][C:77]([F:97])=[CH:78][C:79]=2[C:80]2[CH:95]=[C:84]3[CH:83]=[CH:82][CH:81]=2)[CH2:99][CH2:100]1)[C:57]([O:59][CH3:60])=[O:58])([CH3:54])([CH3:52])[CH3:53]

Participants

3

Reactant 2

HCID 118316325Methyl(2S)-2-(tert-butoxy)-2-[(22S)-5-ethenyl-17-fluoro-4,22,28-trimethyl-21,27-dioxa-1,7,34-triazahexacyclo[26.2.2.16,9.110,14.02,7.015,20]tetratriaconta-2,4,6(34),8,10(33),11,13,15(20),16,18-decaen-3-yl]acetateHCID 118316352Methyl(2S)-2-(tert-butoxy)-2-[(22S)-16,17-difluoro-5-formyl-4,22,28-trimethyl-21,27-dioxa-1,7,34-triazahexacyclo[26.2.2.16,9.110,14.02,7.015,20]tetratriaconta-2,4,6(34),8,10(33),11,13,15(20),16,18-decaen-3-yl]acetate

Product 1

HCID 118316355Methyl(2S)-2-(tert-butoxy)-2-[(22S)-17-fluoro-5-formyl-4,22,28-trimethyl-21,27-dioxa-1,7,34-triazahexacyclo[26.2.2.16,9.110,14.02,7.015,20]tetratriaconta-2,4,6(34),8,10(33),11,13,15(20),16,18-decaen-3-yl]acetateYield 82%

Procedure

Prepared in 82.0% yield from Methyl(2S)-2-(tert-butoxy)-2-[(22S)-5-ethenyl-17-fluoro-4,22,28-trimethyl-21,27-dioxa-1,7,34-triazahexacyclo[26.2.2.16,9.110,14.02,7.015,20]tetratriaconta-2,4,6(34),8,10(33),11,13,15(20),16,18-decaen-3-yl]acetate following the procedure for Methyl(2S)-2-(tert-butoxy)-2-[(22S)-16,17-difluoro-5-formyl-4,22,28-trimethyl-21,27-dioxa-1,7,34-triazahexacyclo[26.2.2.16,9.110,14.02,7.015,20]tetratriaconta-2,4,6(34),8,10(33),11,13,15(20),16,18-decaen-3-yl]acetate. LCMS (ESI, M+1): 686.4.

Sources & evidence

ORD record
ord-203d54e37ff74dbea84e2b40738df964
Source dataset
uspto-grants-2016_08
Patent number
US09409922B2

Reaction notes

Loading…